ExodusPoint Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
133,276
+100,894
| +312% | +$2.79M | 0.03% | 466 |
|
|
2025
Q1 | $719K | Sell |
32,382
-94,779
| -75% | -$2.1M | 0.01% | 957 |
|
|
2024
Q4 | $2.52M | Buy |
127,161
+115,223
| +965% | +$2.28M | 0.02% | 588 |
|
|
2024
Q3 | $298K | Buy |
+11,938
| New | +$298K | ﹤0.01% | 1257 |
|
|
2024
Q1 | – | Sell |
-83,572
| Closed | -$1.47M | – | 1609 |
|
|
2023
Q4 | $1.47M | Buy |
+83,572
| New | +$1.47M | 0.01% | 627 |
|
|
2023
Q2 | – | Sell |
-16,994
| Closed | -$183K | – | 1964 |
|
|
2023
Q1 | $183K | Buy |
+16,994
| New | +$183K | ﹤0.01% | 1488 |
|
|
2022
Q1 | – | Sell |
-19,157
| Closed | -$225K | – | 2371 |
|
|
2021
Q4 | $225K | Sell |
19,157
-20,830
| -52% | -$245K | ﹤0.01% | 1742 |
|
|
2021
Q3 | $455K | Buy |
+39,987
| New | +$455K | 0.01% | 1405 |
|